University of California Researcher Reveals New Findings on Type 1 Diabetes (Expectations and Outcomes From Glucagon-Like Peptide-1 Receptor Agonists As Adjunct Treatment for Type 1 Diabetes - Case Presentations).

MLA

“University of California Researcher Reveals New Findings on Type 1 Diabetes (Expectations and Outcomes From Glucagon-Like Peptide-1 Receptor Agonists As Adjunct Treatment for Type 1 Diabetes - Case Presentations).” Diabetes Week, Jan. 2025, p. 444. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=182017773&authtype=sso&custid=ns315887.

APA

University of California Researcher Reveals New Findings on Type 1 Diabetes (Expectations and Outcomes From Glucagon-Like Peptide-1 Receptor Agonists As Adjunct Treatment for Type 1 Diabetes - Case Presentations). (2025). Diabetes Week, 444.

Chicago

“University of California Researcher Reveals New Findings on Type 1 Diabetes (Expectations and Outcomes From Glucagon-Like Peptide-1 Receptor Agonists As Adjunct Treatment for Type 1 Diabetes - Case Presentations).” 2025. Diabetes Week, January, 444. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=182017773&authtype=sso&custid=ns315887.